SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,380,000 | +15.8% | 12,164 | +0.6% | 0.01% | 0.0% |
| Q2 2020 | $2,055,000 | +76.7% | 12,096 | +20.0% | 0.01% | +50.0% |
| Q1 2020 | $1,163,000 | -32.5% | 10,081 | -37.0% | 0.00% | -20.0% |
| Q4 2019 | $1,722,000 | +34.5% | 15,994 | +6.7% | 0.01% | +25.0% |
| Q3 2019 | $1,280,000 | +11.4% | 14,994 | -9.7% | 0.00% | 0.0% |
| Q2 2019 | $1,149,000 | -5.3% | 16,596 | +0.2% | 0.00% | 0.0% |
| Q1 2019 | $1,213,000 | +23.1% | 16,559 | -4.8% | 0.00% | 0.0% |
| Q4 2018 | $985,000 | -31.5% | 17,386 | -6.8% | 0.00% | -20.0% |
| Q3 2018 | $1,439,000 | +16.1% | 18,664 | +0.0% | 0.01% | 0.0% |
| Q2 2018 | $1,239,000 | -34.0% | 18,662 | -48.0% | 0.01% | -37.5% |
| Q1 2018 | $1,877,000 | -17.3% | 35,862 | -15.5% | 0.01% | -20.0% |
| Q4 2017 | $2,269,000 | +20.4% | 42,417 | +22.5% | 0.01% | +11.1% |
| Q3 2017 | $1,884,000 | -15.4% | 34,620 | -19.6% | 0.01% | -18.2% |
| Q2 2017 | $2,227,000 | -31.6% | 43,046 | -16.9% | 0.01% | -38.9% |
| Q1 2017 | $3,254,000 | +23.9% | 51,771 | +4.0% | 0.02% | +12.5% |
| Q4 2016 | $2,626,000 | +20.8% | 49,770 | +23.7% | 0.02% | +14.3% |
| Q3 2016 | $2,173,000 | +26.7% | 40,230 | -5.2% | 0.01% | +16.7% |
| Q2 2016 | $1,715,000 | +9.2% | 42,430 | -5.2% | 0.01% | 0.0% |
| Q1 2016 | $1,571,000 | -40.4% | 44,780 | -23.7% | 0.01% | -45.5% |
| Q4 2015 | $2,634,000 | +34.8% | 58,680 | +15.8% | 0.02% | +29.4% |
| Q3 2015 | $1,954,000 | -14.6% | 50,665 | +7.2% | 0.02% | -19.0% |
| Q2 2015 | $2,287,000 | +175.2% | 47,250 | +101.1% | 0.02% | +162.5% |
| Q1 2015 | $831,000 | +17.5% | 23,500 | +6.8% | 0.01% | +14.3% |
| Q4 2014 | $707,000 | -10.6% | 22,000 | +3.4% | 0.01% | -22.2% |
| Q3 2014 | $791,000 | -31.3% | 21,275 | -36.4% | 0.01% | -40.0% |
| Q2 2014 | $1,152,000 | +23.6% | 33,450 | +63.6% | 0.02% | +7.1% |
| Q1 2014 | $932,000 | +183.3% | 20,450 | +147.9% | 0.01% | +133.3% |
| Q4 2013 | $329,000 | +2430.8% | 8,250 | +2659.2% | 0.01% | – |
| Q3 2013 | $13,000 | +160.0% | 299 | +100.7% | 0.00% | – |
| Q2 2013 | $5,000 | – | 149 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |